Meridian Bioscience, Inc. Announces New Exclusive Canadian Distribution Agreement with Somagen Diagnostics

Published: Sep 10, 2008

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced the commencement of a new exclusive Canadian distribution agreement with Somagen Diagnostics, Edmonton, Alberta. This decision is consistent with Meridian’s stated commitment to expand its non-US businesses.

Back to news